163 related articles for article (PubMed ID: 15604945)
1. Measurement of skeletal muscle glucose utilization by dynamic 18F-FDG PET without arterial blood sampling.
Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
Nucl Med Commun; 2005 Jan; 26(1):31-7. PubMed ID: 15604945
[TBL] [Abstract][Full Text] [Related]
2. Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET.
Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
J Nucl Med; 2003 Oct; 44(10):1592-8. PubMed ID: 14530472
[TBL] [Abstract][Full Text] [Related]
3. Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT.
Gheysens O; Postnov A; Deroose CM; Vandermeulen C; de Hoon J; Declercq R; Dennie J; Mixson L; De Lepeleire I; Van Laere K; Klimas M; Chakravarthy MV
J Nucl Med; 2015 Oct; 56(10):1520-6. PubMed ID: 26229142
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.
Yokoyama I; Yonekura K; Moritan T; Tateno M; Momose T; Ohtomo K; Inoue Y; Nagai R
J Nucl Med; 2001 Jul; 42(7):1005-10. PubMed ID: 11438619
[TBL] [Abstract][Full Text] [Related]
5. Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
Trägårdh M; Møller N; Sørensen M
J Nucl Med; 2015 Sep; 56(9):1366-71. PubMed ID: 26159590
[TBL] [Abstract][Full Text] [Related]
6. Use of arterialised venous instead of arterial blood for measurement of myocardial glucose metabolism during euglycaemic-hyperinsulinaemic clamping.
van der Weerdt AP; Klein LJ; Visser CA; Visser FC; Lammertsma AA
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):663-9. PubMed ID: 11976805
[TBL] [Abstract][Full Text] [Related]
7. Improved derivation of input function in dynamic mouse [18F]FDG PET using bladder radioactivity kinetics.
Wong KP; Zhang X; Huang SC
Mol Imaging Biol; 2013 Aug; 15(4):486-96. PubMed ID: 23322346
[TBL] [Abstract][Full Text] [Related]
8. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
9. Quantitative brain FDG/PET studies using dynamic aortic imaging.
Dhawan V; Takikawa S; Robeson W; Spetsieris P; Chaly T; Dahl R; Zanzi I; Bandyopadhyay D; Margouleff D; Eidelberg D
Phys Med Biol; 1994 Sep; 39(9):1475-87. PubMed ID: 15552117
[TBL] [Abstract][Full Text] [Related]
10. Simplified quantification of small animal [18F]FDG PET studies using a standard arterial input function.
Meyer PT; Circiumaru V; Cardi CA; Thomas DH; Bal H; Acton PD
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):948-54. PubMed ID: 16699768
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
Rudd JH; Myers KS; Bansilal S; Machac J; Pinto CA; Tong C; Rafique A; Hargeaves R; Farkouh M; Fuster V; Fayad ZA
J Nucl Med; 2008 Jun; 49(6):871-8. PubMed ID: 18483100
[TBL] [Abstract][Full Text] [Related]
12. Measurement of input functions in rodents: challenges and solutions.
Laforest R; Sharp TL; Engelbach JA; Fettig NM; Herrero P; Kim J; Lewis JS; Rowland DJ; Tai YC; Welch MJ
Nucl Med Biol; 2005 Oct; 32(7):679-85. PubMed ID: 16243642
[TBL] [Abstract][Full Text] [Related]
13. Image-derived input function in dynamic human PET/CT: methodology and validation with 11C-acetate and 18F-fluorothioheptadecanoic acid in muscle and 18F-fluorodeoxyglucose in brain.
Croteau E; Lavallée E; Labbe SM; Hubert L; Pifferi F; Rousseau JA; Cunnane SC; Carpentier AC; Lecomte R; Bénard F
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1539-50. PubMed ID: 20437239
[TBL] [Abstract][Full Text] [Related]
14. Glucose metabolism in brain tumours can be estimated using [18F]2-fluorodeoxyglucose positron emission tomography and a population-derived input function scaled using a single arterialised venous blood sample.
Brock CS; Young H; Osman S; Luthra SK; Jones T; Price PM
Int J Oncol; 2005 May; 26(5):1377-83. PubMed ID: 15809731
[TBL] [Abstract][Full Text] [Related]
15. Impact of reversible trapping of tracer and the presence of blood metabolites on measurements of myocardial glucose utilization performed by PET and 18F-fluorodeoxyglucose using the Patlak method.
Herrero P; Dence CS; Sharp TL; Welch MJ; Gropler RJ
Nucl Med Biol; 2004 Oct; 31(7):883-92. PubMed ID: 15464390
[TBL] [Abstract][Full Text] [Related]
16. Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies.
de Geus-Oei LF; Visser EP; Krabbe PF; van Hoorn BA; Koenders EB; Willemsen AT; Pruim J; Corstens FH; Oyen WJ
J Nucl Med; 2006 Jun; 47(6):945-9. PubMed ID: 16741303
[TBL] [Abstract][Full Text] [Related]
17. Determination of the lumped constant for [18F] fluorodeoxyglucose in human skeletal muscle.
Kelley DE; Williams KV; Price JC; Goodpaster B
J Nucl Med; 1999 Nov; 40(11):1798-804. PubMed ID: 10565773
[TBL] [Abstract][Full Text] [Related]
18. Liver kinetics of glucose analogs measured in pigs by PET: importance of dual-input blood sampling.
Munk OL; Bass L; Roelsgaard K; Bender D; Hansen SB; Keiding S
J Nucl Med; 2001 May; 42(5):795-801. PubMed ID: 11337579
[TBL] [Abstract][Full Text] [Related]
19. Assessment of brain glucose metabolism with input function determined from brain PET images by means of Bayesian ICA and MCMC methods.
Berradja K; Boughanmi N
Comput Med Imaging Graph; 2012 Dec; 36(8):620-6. PubMed ID: 22884568
[TBL] [Abstract][Full Text] [Related]
20. Cerebral arterial inflow assessment with 18F-FDG PET: methodology and feasibility.
Benathan-Tordjmann J; Bailly P; Meyer ME; Daouk J
Comput Methods Programs Biomed; 2014 Oct; 116(3):177-83. PubMed ID: 25015567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]